Skip to main content
. 2022 Apr 11;9:868640. doi: 10.3389/fnut.2022.868640

FIGURE 1.

FIGURE 1

Clinical trial diagram. Clinical trial diagram based on the CONSORT. A total of 42 potential participants were screened, and 30 eligible participants were selected and randomized into nicotinamide mononucleotide (NMN) and placebo groups in a 1:1 ratio. One participant in placebo group was dropped out from the study at 8-week, and 29 participants completed the study.